Pfizer partner BioNTech scores €100M debt financing to fund COVID-19 vaccine production in Europe

BioNTech and Pfizer are among the front-runners in the closely watched COVID-19 vaccine race, and as they simultaneously work through development and scale up manufacturing, BioNTech has scored a €100 million financing agreement to help fund production in Europe.